NFL players can track and sell their own health data

Professional athletes know that it's not just the matches and training sessions that matter: it's what you do in your downtime too. Whoop's wearable straps specialise in this area, tracking your movement, heart rate, and ambient temperature to better…

A 3D-printed patch could help you recover from a heart attack

Scientists have dreamed of easily patching up heart tissue in the wake of heart attacks, but there are always gotchas: for example, it's no mean feat to replicate the complex structures of real tissue. However, there may be a solution in sight. Res…

First gene therapy drug proves a flop in the market

When UniQure launched the first commercial gene therapy drug, Glybera, it promised a minor revolution in medicine. By using custom viruses to deliver genes, it could reportedly cure a rare disease (lipoprotein lipase deficiency) with just one round o…

Theranos says it has been mischaracterized in allegations the company faked tests

 Theranos secretly bought lab equipment through a shell company, faked tests and inappropriately pumped up its financial outlook to investors, according to allegations in recently unsealed court documents, first reported by the Wall Street Journal. Partner Fund Management LP, a hedge fund management firm which invested $96 million in Theranos filed the claim in Delaware Chancery Court on… Read More

Form an orderly queue! Google wants your blood (and other bodily fluids). Oh and your medical records

 Alphabet’s (Google’s) life sciences division Verily has launched its public pitch for a massive, multi-year health study it’s leading, along with Duke University School of Medicine, Stanford Medicine, and Google proper. Read More

Elon Musk’s Neuralink wants to turn cloud-based AI into an extension of our brains

 Elon Musk has been working on a Neuralink, a human-computer brain interface company, in whatever spare moments he has between running Tesla and also running SpaceX. Neuralink’s ultimate aim may actually be the most ambitious of all three of his companies, surprisingly, and a new exploration of the foundational ideas behind Neuralink on Wait But Why goes deep within what Musk hopes to… Read More

ZappRX gets $25 million from Chinese VC’s to expand into the U.S. drug prescription market

 ZappRX, the app that aims to make it easier to manage specialty drug prescriptions, has pulled in $25 million in Series B funding led by Qiming US, the Chinese venture outfit’s stateside health care fund. GV (formerly Google Ventures) and GlaxoSmithKline’s funding arm SR One were also in the round and GV’s Krishna Yeshwant and Qiming US’s Mark McDade will now join… Read More

Facebook plans ethics board to monitor its brain-computer interface work

 Facebook will assemble an independent Ethical, Legal and Social Implications (ELSI) panel to oversee its development of a direct brain-to-computer typing interface it previewed today at its F8 conference. Facebook’s R&D department Building 8’s head Regina Dugan tells TechCrunch, “It’s early days . . . we’re in the process of forming it right now.” Read More